AbbVie Inc (ABBV)
159.59
-7.70
(-4.60%)
USD |
NYSE |
Apr 26, 16:00
160.00
+0.41
(+0.26%)
After-Hours: 18:24
AbbVie Cash from Investing (TTM): -2.009B for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -2.009B |
September 30, 2023 | -1.657B |
June 30, 2023 | -2.00M |
March 31, 2023 | 469.00M |
December 31, 2022 | -623.00M |
September 30, 2022 | -1.32B |
June 30, 2022 | -3.221B |
March 31, 2022 | -3.593B |
December 31, 2021 | -2.344B |
September 30, 2021 | -1.826B |
June 30, 2021 | -2.36B |
March 31, 2021 | -37.77B |
December 31, 2020 | -37.56B |
September 30, 2020 | -37.54B |
June 30, 2020 | -35.02B |
March 31, 2020 | 494.00M |
December 31, 2019 | 596.00M |
September 30, 2019 | 928.00M |
June 30, 2019 | -1.413B |
March 31, 2019 | -586.00M |
December 31, 2018 | -1.006B |
September 30, 2018 | -522.00M |
June 30, 2018 | 332.00M |
March 31, 2018 | -37.00M |
December 31, 2017 | -274.00M |
Date | Value |
---|---|
September 30, 2017 | -594.00M |
June 30, 2017 | -684.00M |
March 31, 2017 | -5.30B |
December 31, 2016 | -6.074B |
September 30, 2016 | -6.252B |
June 30, 2016 | -5.308B |
March 31, 2016 | -13.52B |
December 31, 2015 | -12.94B |
September 30, 2015 | -10.12B |
June 30, 2015 | -13.15B |
March 31, 2015 | -1.002B |
December 31, 2014 | -926.00M |
September 30, 2014 | -3.317B |
June 30, 2014 | -1.997B |
March 31, 2014 | -1.405B |
December 31, 2013 | 879.00M |
September 30, 2013 | 550.00M |
June 30, 2013 | -292.00M |
March 31, 2013 | -727.00M |
December 31, 2012 | -2.418B |
September 30, 2012 | -1.703B |
June 30, 2012 | 577.02M |
March 31, 2012 | 433.64M |
December 31, 2011 | 553.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-37.77B
Minimum
Mar 2021
928.00M
Maximum
Sep 2019
-8.725B
Average
-1.826B
Median
Sep 2021
Cash from Investing (TTM) Benchmarks
Amgen Inc | -26.20B |
Immunogen Inc (DELISTED) | -1.889M |
Johnson & Johnson | 878.00M |
Eli Lilly and Co | -7.153B |
Merck & Co Inc | -14.08B |